Survodutide dosage by bodyweight
Reference dose ranges scaled across bodyweight bands, anchored to the most-cited research dose (600 mcg @ 75 kg). Educational only — never a recommendation.
| Bodyweight band | Reference dose range | At U-100 (1 mg/mL) | Vol. on U-100 (5 mg / 2 mL) | 5× t½ elapsed |
|---|---|---|---|---|
| <60 kg / <132 lb | 374–506 mcg | 0.37–0.51 mL | 15–20 units0.15–0.20 mL | — |
| 60–75 kg / 132–165 lb | 459–621 mcg | 0.46–0.62 mL | 18–25 units0.18–0.25 mL | — |
| 75–90 kg / 165–198 lb | 561–759 mcg | 0.56–0.76 mL | 22–30 units0.22–0.30 mL | — |
| 90–105 kg / 198–231 lb | 663–897 mcg | 0.66–0.90 mL | 27–36 units0.27–0.36 mL | — |
| >105 kg / >231 lb | 765–1035 mcg | 0.77–1.03 mL | 31–41 units0.31–0.41 mL | — |
Volume column assumes a standard 5 mg vial reconstituted with 2 mL bacteriostatic water (concentration 2.5 mg/mL); insulin units shown for a U-100 syringe. No published half-life on file for Survodutide; the elapsed-time column is hidden.
Survodutide by goal
Read Survodutide's profile and dosing through a specific research-goal lens.
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.